These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8934730)
21. Adjuvant chemotherapy of stage III colon cancer. Benson AB Semin Oncol; 2005 Dec; 32(6 Suppl 9):S74-7. PubMed ID: 16399437 [TBL] [Abstract][Full Text] [Related]
22. The French experience with infusional 5-fluorouracil in advanced colorectal cancer. de Gramont A; Louvet C; Krulik M J Infus Chemother; 1996; 6(3):133-6. PubMed ID: 9229324 [TBL] [Abstract][Full Text] [Related]
23. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil. Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966 [TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma. Hillner BE; Schrag D; Sargent DJ; Fuchs CS; Goldberg RM Cancer; 2005 Nov; 104(9):1871-84. PubMed ID: 16177989 [TBL] [Abstract][Full Text] [Related]
25. Continuous infusion of 5-fluorouracil with versus without low-dose, consecutive administration of cisplatin in advanced colorectal cancer. A prospective randomized phase II study. Nakata B; Sowa M; Tsuji A; Kamano T; Sasaki K; Fukunaga Y; Takahashi M; Tsujitani S; Mikami Y; Mitachi Y; Nishimura S; Araki H; Yamamitsu S; Hirakawa K; Tominaga S; Shirasaka T; Inokuchi K J Exp Clin Cancer Res; 2007 Mar; 26(1):51-60. PubMed ID: 17550132 [TBL] [Abstract][Full Text] [Related]
26. Controversial issues in 5-fluorouracil infusion use. Dose intensity, treatment duration, and cost comparisons. Anderson N; Lokich J Cancer; 1992 Aug; 70(4 Suppl):998-1002. PubMed ID: 1638471 [TBL] [Abstract][Full Text] [Related]
28. Biomodulation of Fluorouracil in colorectal cancer. Ardalan B; Luis R; Jaime M; Franceschi D Cancer Invest; 1998; 16(4):237-51. PubMed ID: 9589033 [TBL] [Abstract][Full Text] [Related]
37. Development of treatment for advanced colorectal cancer: infusional 5-FU and the role of new agents. Schmoll HJ Eur J Cancer; 1996; 32A Suppl 5():S18-22. PubMed ID: 8958038 [TBL] [Abstract][Full Text] [Related]